Condition

Myelodysplastic Syndrome

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 12 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12
Recruiting2
Common interventions25
Lead sponsors shown11
Advertisement

Clinical trials

12 shown
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044 · 2025-12-18
RECRUITING
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerNCT05969860 · 2023-08-23
RECRUITING
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic CancersNCT04083170 · 2022-10-06
TERMINATED
SARS-CoV-2 Donor-Recipient Immunity TransferNCT04666025 · 2020-09-23
COMPLETED
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaNCT03096782 · 2017-10-13
COMPLETED
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerNCT03154190 · 2017-08-08
COMPLETED
Phase I Study of Milatuzumab for Graft Versus Host DiseaseNCT01663766 · 2013-12-01
TERMINATED
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)NCT02085798 · 2012-12-17
COMPLETED
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological CancersNCT01240525 · 2011-11-01
UNKNOWN
SCRI Tissue Testing RegistryNCT00965861 · 2010-05-01
TERMINATED
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell TransplantNCT00510315 · 2007-07-01
COMPLETED
Nonmyeloablative Allogeneic TransplantNCT01272817 · 2001-10-01
COMPLETED

Common interventions

Questionnaire AdministrationOTHER3CyclophosphamideDRUG2FludarabineDRUG2Total-Body IrradiationRADIATION2Umbilical Cord Blood TransplantationPROCEDURE2Anti-Thymocyte GlobulinBIOLOGICAL1Best PracticeOTHER1Biospecimen CollectionPROCEDURE1BusulfanDRUG1Cancer Therapeutic ProcedureDRUG1CD4 DLIOTHER1Clinical EncounterPROCEDURE1ClofarabineDRUG1Diagnostic Laboratory Biomarker AnalysisOTHER1DilanubicelBIOLOGICAL1Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretionOTHER1Electronic Health Record ReviewOTHER1Filgrastim-sndzBIOLOGICAL1Home Health EncounterOTHER1Laboratory Biomarker AnalysisOTHER1MelphalanDRUG1milatuzumabDRUG1Mycophenolate MofetilDRUG1No DLIOTHER1Nonmyeloablative Allogeneic TransplantPROCEDURE1

Trial status mix

COMPLETED6
TERMINATED3
RECRUITING2
UNKNOWN1

Phase mix

PHASE25
NA2
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.